Justin A. Renz

2015

In 2015, Justin A. Renz earned a total compensation of $1.9M as Former Executive Vice President, Chief Financial Officer & Treasurer at Karyopharm Therapeutics, a 76% decrease compared to previous year.

Compensation breakdown

Non-Equity Incentive Plan$85,200
Option Awards$876,713
Salary$355,000
Stock Awards$537,300
Other$10,980
Total$1,865,193

Renz received $876.7K in option awards, accounting for 47% of the total pay in 2015.

Renz also received $85.2K in non-equity incentive plan, $355K in salary, $537.3K in stock awards and $11K in other compensation.

Rankings

In 2015, Justin A. Renz's compensation ranked 5,006th out of 13,638 executives tracked by ExecPay. In other words, Renz earned more than 63.3% of executives.

ClassificationRankingPercentile
All
5,006
out of 13,638
63rd
Division
Manufacturing
1,845
out of 5,190
65th
Major group
Chemicals And Allied Products
660
out of 1,854
64th
Industry group
Drugs
525
out of 1,528
66th
Industry
Pharmaceutical Preparations
413
out of 1,182
65th
Source: SEC filing on April 28, 2017.

Renz's colleagues

We found three more compensation records of executives who worked with Justin A. Renz at Karyopharm Therapeutics in 2015.

2015

Michael Kauffman

Karyopharm Therapeutics

Chief Executive Officer

2015

Sharon Shacham

Karyopharm Therapeutics

Chief Scientific Officer

2015

Christopher Primiano

Karyopharm Therapeutics

General Counsel

You may also like